Scarica l'app Stockscreener
23.00
0.13%
-0.03
Dopo l'orario di chiusura:
23.00
Precedente Chiudi:
$23.03
Aprire:
$22.29
Volume 24 ore:
143.50K
Relative Volume:
0.44
Capitalizzazione di mercato:
$1.56B
Reddito:
$350.00K
Utile/perdita netta:
$-72.78M
Rapporto P/E:
-21.30
EPS:
-1.08
Flusso di cassa netto:
$-54.46M
1 W Prestazione:
+6.98%
1M Prestazione:
+22.02%
6M Prestazione:
+21.12%
1 anno Prestazione:
+37.48%
Intervallo 1D:
$22.16
$23.66
Intervallo di 1 settimana:
$19.52
$23.66
Portata 52W:
$12.56
$26.30
Pulse Biosciences Inc Stock (PLSE) Company Profile
Nome
Pulse Biosciences Inc
Settore
Industria
Telefono
510-906-4600
Indirizzo
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
23.00 | 1.56B | 350.00K | -72.78M | -54.46M | -1.08 |
ISRG
Intuitive Surgical Inc
|
452.07 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.56 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
44.28 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.09 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Iniziato | Mizuho | Outperform |
| 2025-07-07 | Iniziato | Oppenheimer | Outperform |
| 2021-07-27 | Iniziato | Stephens | Overweight |
| 2021-03-11 | Iniziato | Maxim Group | Buy |
| 2021-01-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-12 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Pulse Biosciences Inc Borsa (PLSE) Ultime notizie
Aug Swings: Is Pulse Biosciences Inc exposed to currency risks2026 PostEarnings & Capital Efficient Trading Techniques - baoquankhu1.vn
How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing - Stock Traders Daily
PLSE SEC FilingsPulse Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Pulse Biosciences (PLSE) awards CTO 100,000 Restricted Stock Units - Stock Titan
Pulse Biosciences, Inc. (PLSE) stock price, news, quote and history - Yahoo Finance Australia
Pulse Biosciences, Inc. (PLSE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference - businesswire.com
Pulse Biosciences Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Pulse Biosciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Q4 2025 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
Q3 2025 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
Q1 2025 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
PLSE accelerates cardiac catheter program after breakthrough AFib data - MSN
Pulse Biosciences Shifts Focus to Catheter Electrophysiology Tech - Medical Product Outsourcing
How Pulse Biosciences’ nPulse AFib Refocus Will Impact Pulse Biosciences (PLSE) Investors - simplywall.st
Pulse Biosciences (NASDAQ:PLSE) Shares Down 7%What's Next? - MarketBeat
PLSE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Pulse Biosciences, Inc. 8-K SEC Filing March 23, 2026 – Company Information, NASDAQ Listing, and Key Details - Minichart
Pulse Biosciences Grants RSUs to Chief Technology Officer - TipRanks
Pulse Biosciences (NASDAQ: PLSE) awards CTO 100,000-share RSU grant - Stock Titan
PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data - sharewise.com
PLSE Speeds Up Cardiac Catheter Initiative Following Landmark AFib Findings - Bitget
Stock Analysis: Is Pulse Biosciences Inc exposed to currency risks2026 Short Interest & Risk Managed Trade Strategies - baoquankhu1.vn
(PLSE) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Pulse Biosciences to accelerate Pulse Cardiac Catheter Ablation System - msn.com
Assessing Pulse Biosciences (PLSE) Valuation After The nPulse Cardiac Catheter Ablation Pivot - Sahm
Pulse Biosciences Touts 96% 12-Month Rhythm Control, Targets Q2 Start for U.S. AF IDE Study - Yahoo Finance
PLSE Stock Price, Quote & Chart | PULSE BIOSCIENCES INC (NASDAQ:PLSE) - ChartMill
What's Going With Pulse Biosciences Stock On Monday? - MSN
Pulse Biosciences targets CE mark submission in 2026 as nPulse platform advances clinical milestones - MSN
Pulse Biosciences at Oppenheimer Conference: Promising AF Ablation Results By Investing.com - Investing.com India
Pulse Biosciences (NASDAQ:PLSE) Stock Price Passes Above Fifty Day Moving AverageWhat's Next? - MarketBeat
Pulse Biosciences shifts focus to cardiac catheter program By Investing.com - Investing.com South Africa
Pulse Biosciences (PLSE) Is Up 14.8% After Refocusing On nPulse AFib Catheter PlatformHas The Bull Case Changed? - simplywall.st
Pulse Biosciences Announces Organizational Realignment to Accelerate Cardiac Catheter Program After Exceptional AFib Clinical Results - Minichart
Pulse Biosciences Realigns Strategy Around nPulse AFib Platform - TipRanks
Pulse Biosciences (PLSE) realigns strategy around nPulse AFib catheter program - Stock Titan
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data - BioSpace
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program - marketscreener.com
Pulse Biosciences (PLSE) Prioritizes nPulse Cardiac Catheter Dev - GuruFocus
Pulse Biosciences shifts focus to cardiac catheter program - Investing.com
Is Pulse Biosciences’ (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? - Yahoo Finance
A Look At Pulse Biosciences (PLSE) Valuation As Thyroid Cancer Feasibility Study Begins - Yahoo Finance
Pulse Biosciences enrolls first patients in thyroid cancer study - Investing.com Nigeria
Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And DCF Estimate Gap - simplywall.st
Responsive Playbooks and the PLSE Inflection - Stock Traders Daily
Pulse Biosciences Inc Azioni (PLSE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):